coverage from uk, page-9

Population of the UK is nearly 4 times our population - so for starters it's a much larger market.
It should also open up the European market from here, with much higher population again.

I'm reluctant to say this might take off again, being another little biotech that's had a good run, but I do feel the market cap is a little low for the product potential, and the fact that the market love anything that can help with anything to do with cancer - but the market will decide....

Certainly had a very strong finish this afternoon, and suggests a strong day tomorrow.
Would be good to get some more news out of the UK too.

Thanks for those articles.